These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25066623)

  • 1. Subjectively perceived personality and mood changes associated with subthalamic stimulation in patients with Parkinson's disease.
    Lewis CJ; Maier F; Horstkötter N; Zywczok A; Witt K; Eggers C; Meyer TD; Dembek TA; Maarouf M; Moro E; Zurowski M; Woopen C; Kuhn J; Timmermann L
    Psychol Med; 2015 Jan; 45(1):73-85. PubMed ID: 25066623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.
    Castelli L; Perozzo P; Zibetti M; Crivelli B; Morabito U; Lanotte M; Cossa F; Bergamasco B; Lopiano L
    Eur Neurol; 2006; 55(3):136-44. PubMed ID: 16682797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.
    Maier F; Lewis CJ; Horstkoetter N; Eggers C; Dembek TA; Visser-Vandewalle V; Kuhn J; Zurowski M; Moro E; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2016 Mar; 24():41-7. PubMed ID: 26827110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.
    Lewis CJ; Maier F; Horstkötter N; Eggers C; Visser-Vandewalle V; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    J Neurol; 2015 Feb; 262(2):337-45. PubMed ID: 25381461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of mood disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation].
    Maes H; Vingerhoets F; Berney A
    Rev Med Suisse; 2011 Feb; 7(282):385-8. PubMed ID: 21416865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does subthalamic stimulation induce personality modifications in Parkinson's disease? A Rorschach Test explorative study.
    Castelli L; Perozzo P; Caglio M; Rizzi L; Zibetti M; Lanotte M; Lopiano L
    Acta Neurol Belg; 2008 Mar; 108(1):5-8. PubMed ID: 18575180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.
    Serranová T; Jech R; Dušek P; Sieger T; Růžička F; Urgošík D; Růžička E
    Mov Disord; 2011 Oct; 26(12):2260-6. PubMed ID: 21780183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.
    Berney A; Panisset M; Sadikot AF; Ptito A; Dagher A; Fraraccio M; Savard G; Pell M; Benkelfat C
    Mov Disord; 2007 Jun; 22(8):1093-6. PubMed ID: 17394245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic and motor function comparison of deep brain stimulation of the zona incerta and subthalamic nucleus.
    Burrows AM; Ravin PD; Novak P; Peters ML; Dessureau B; Swearer J; Pilitsis JG
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):125-30; discussion 130-1. PubMed ID: 21869721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease.
    Cury RG; Galhardoni R; Fonoff ET; Dos Santos Ghilardi MG; Fonoff F; Arnaut D; Myczkowski ML; Marcolin MA; Bor-Seng-Shu E; Barbosa ER; Teixeira MJ; Ciampi de Andrade D
    Neurology; 2014 Oct; 83(16):1403-9. PubMed ID: 25217059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.